Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) Research & Development: 2015-2024

Historic Research & Development for Anaptysbio (ANAB) over the last 10 years, with Dec 2024 value amounting to $163.8 million.

  • Anaptysbio's Research & Development fell 25.60% to $31.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $153.0 million, marking a year-over-year decrease of 1.15%. This contributed to the annual value of $163.8 million for FY2024, which is 23.86% up from last year.
  • Per Anaptysbio's latest filing, its Research & Development stood at $163.8 million for FY2024, which was up 23.86% from $132.3 million recorded in FY2023.
  • Anaptysbio's 5-year Research & Development high stood at $163.8 million for FY2024, and its period low was $80.0 million during FY2020.
  • In the last 3 years, Anaptysbio's Research & Development had a median value of $132.3 million in 2023 and averaged $128.3 million.
  • In the last 5 years, Anaptysbio's Research & Development fell by 19.44% in 2020 and then skyrocketed by 48.97% in 2023.
  • Yearly analysis of 5 years shows Anaptysbio's Research & Development stood at $80.0 million in 2020, then rose by 23.08% to $98.5 million in 2021, then dropped by 9.85% to $88.8 million in 2022, then skyrocketed by 48.97% to $132.3 million in 2023, then climbed by 23.86% to $163.8 million in 2024.